Newbridge Financial Services Group, Inc. Sangamo Therapeutics, Inc Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$0.42 - $1.38 $15,330 - $50,369	36,500 New	36,500 $24,000
Q3 2022 Oct 13, 2022	SELL	$4.27 - $6.39 $4,270 - $6,390	-1,000 Reduced 33.33%	2,000 $10,000
Q2 2022 Jul 15, 2022	BUY	$3.28 - $6.21 $4,920 - $9,315	1,500 Added 100.0%	3,000 $12,000
Q3 2021 Oct 27, 2021	BUY	$9.01 - $12.01 $13,515 - $18,015	1,500 New	1,500 $14,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.